21财经11月11日电,福泰制药(VertexPharmaceuticalsInc.,纳斯达克:VRTX)首席执行官兼总裁ReshmaKewalramani提交Form4持股变动声明。11月6日,ReshmaKewalramani通过1笔交易合计减持11866股普通股,成交价格531.53美元,套现约630.71万美元。减持后,ReshmaKewalramani直接持有公司普通股86471股。本次...
Source Link21财经11月11日电,福泰制药(VertexPharmaceuticalsInc.,纳斯达克:VRTX)首席执行官兼总裁ReshmaKewalramani提交Form4持股变动声明。11月6日,ReshmaKewalramani通过1笔交易合计减持11866股普通股,成交价格531.53美元,套现约630.71万美元。减持后,ReshmaKewalramani直接持有公司普通股86471股。本次...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.